FDA Adverse Event Other Summary report: N

QUILL SRS

MDR report key: 1899136 · Received October 28, 2010

Report

Report Number
2522801-2010-00033
Event Type
Other
Date Received
October 28, 2010
Date of Event
June 8, 2010
Report Date
October 28, 2010
Manufacturer
SURGICAL SPECIALTIES CORP. (DBA ANGIOTECH)
Product Code
GAM
PMA / PMN Number
K072028
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

NO SAMPLES WERE AVAILABLE FOR EVAL. THEREFORE, NO TESTING CAN BE PERFORMED. THE ITEM/LOT CODE INFO WAS NOT PROVIDED. THEREFORE, THE EXPIRATION DATE AND MFG DATE ARE UNK. ADDITIONAL ITEM REPORTED BY THIS CUSTOMER: 2-0 PDO; MODEL/CATALOG #: UNK; LOT #: UNK; EXP DATE: UNK; DEVICE MFR DATE: UNK; 510 (K) #: K051609. METHOD: THE DEVICES WERE NOT AVAILABLE FOR EVAL. NO PRODUCT EVAL CAN BE PERFORMED. RESULTS/CONCLUSION: THE DEVICES WERE NOT RETURNED FOR EVAL. NO PRODUCT EVAL CAN BE PERFORMED. WITHOUT THE FINISHED GOOD LOT NUMBERS, RELEVANT PORTIONS OF THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED. IT IS UNCERTAIN IF THE QUILL SRS MATERIAL ATTRIBUTED TO THIS EVENT. A DEFINITIVE CONCLUSION CANNOT BE DRAWN AT THIS TIME. (B)(4), QUILL SRS MONODERM / QUILL SRS PDO ITEM YA-1024Q / ITEM UNK, SIZE 2-0, LOT UNK.

Description of Event or Problem · 1

THE DATE OF EVENT IS ESTIMATED. DR (B)(6) PERFORMED A TOTAL HIP ARTHROPLASTY USING QUILL SRS 2-0 PDO FOR DEEP LAYER CLOSURE AND 2-0 MONODERM FOR CLOSURE OF THE SKIN. THE SURGEON STATED THAT ON (B)(6) 2010, THE PT EXPERIENCED WOUND DEHISCENCE. THE SURGEON WAS NOT CERTAIN WHICH LAYER DEHISCED. CULTURE AND SENSITIVITIES WERE TAKEN AND SHOWED A GROWTH OF (B)(6). MEDICAL AND SURGICAL INTERVENTION WAS REQUIRED FOR TREATMENT OF THE DEHISCENCE AND INFECTION. THE PT HEALED WITH NO FURTHER COMPLICATIONS. NO ADDITIONAL INFO WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 QUILL SRS BARBED SUTURE/NEEDLE GAM SURGICAL SPECIALTIES CORP. (DBA ANGIOTECH) YA-1024Q UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention